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Background: Diabetic patients are at the risk of cardiac autonomic neuropathy (CAN) and arterial stiffness. This
study aimed to investigate the association of heart rate variability (HRV) as an index for CAN and pulse wave
velocity (PWV) as an index for arterial stiffness.
Methods: Uncomplicated diabetes type-2 patients who had no apparent history of cardiovascular condition
underwent HRV and PWV measurements and the results were compared with the control group consisting of
non-diabetic peers. Also, the findings were adjusted for the cardiovascular risk factors and other confounding factors.
Results: A total of 64 diabetic patients (age= 52.08±8.50 years; males=33 [51.6%]) were compared with 57 controls
(age= 48.74±6.18 years; males=25 [43.9%]) in this study. Hypertension, dyslipidemia, and thereby systolic blood
pressure and statin use were significantly more frequent in the diabetic group, while the serum levels of cholesterol,
HDL-C and LDL-C were significantly higher in the controls. Pulse wave was significantly increased in the diabetic
patients (p<0.001). Main HRV parameters were significantly lower in diabetics than in controls. After adjustment for
the confounders, PWV and HRV remained significantly different between the groups (p=0.01 and p=0.004, respectively).
Multiple logistic regression of the association between pulse wave velocity and HRV index was independently
significant both in diabetics and controls.
Conclusions: There exists a significant relationship between heart rate variability and arterial stiffness as a measure
for atherosclerosis in diabetic patients, although the role of the confounding factors is noteworthy.
Keywords: Heart rate variability, Arterial stiffness, Pulse wave velocity, Diabetes mellitus type 2, Cardiac autonomic
neuropathyIntroduction
More than half of the mortality in diabetic patients
occurs due to cardiovascular disease [1]. Although most of
this risk stems from atherosclerosis along with vascular
ageing, there are other conditions involved [2]. Cardiac
autonomic neuropathy (CAN) is a serious complication of
diabetes mellitus, shown to influence both mortality and* Correspondence: fakhrzad@tums.ac.ir
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distribution, and reproduction in any mediumcardiovascular events in these patients [3]. As the heart
rate and vascular tone are regulated via the autonomic
system, CAN can increase heart rate variability and
decrease myocardial perfusion [4].
On the other hand, heart rate variability (HRV) can be
assessed easily to measure CAN, much earlier than its
clinical appearance [5]. It has been shown that low HRV
is associated with increased mortality in patients with
ischemic heart disease or diabetes mellitus [3,6]. HRV is
also a sensitive indicator of baroreflex control, specific-
ally the vagal control [7,8]. Therefore, arterial stiffness
may affect baroreceptor function and thereby, HRV.
Increased arterial stiffness evaluated by pulse wave velocity
(PWV) and/or augmentation index has been associatedentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cardiovascular prognosis both in general population [9,10]
and specific disease groups, including diabetes mellitus
[11]. Therefore, understanding the exact relationship of
heart rate variability, as an index for CAN, with arterial
stiffness is crucial.
The aims of the present study were to investigate (i)
the association of disturbed PWV, as an index for
increased arterial stiffness, and HRV, as an index for
CAN, in the presence or absence of uncomplicated
diabetes mellitus and (ii) the relation of PWV with HRV
in uncomplicated diabetic patients.
Methods
In this case–control study, uncomplicated diabetic type
2 (T2DM) patients who were referred to the Diabetes
clinic of Dr. Shariati hospital, Tehran University of
Medical Sciences, Tehran, Iran, between August 2011
and December 2012 were recruited. The control group
consisted of their spouse or relatives who were proved
to be non-diabetic. The inclusion criteria were defined
as both sexes, aged between 30 and 65 years. Individuals
with clinically proven coronary heart disease, diabetic
foot, diabetic retinopathy or nephropathy, renal failure
(GFR < 90), history of malignancy, and cirrhosis were
excluded from the study. Height was measured with a
Stadiometer, and weight was assessed by a calibrated
beam balance. Body mass index (BMI) was calculated as
weight (Kg) divided by height (M) squared. Blood pres-
sure was measured twice (5 minutes apart) using a
standard calibrated mercury sphygmomanometer on
both right and left arms after the participants had been
sitting calm for at least 10 minutes. The highest blood
pressure of two sides was considered as participant’s
blood pressure.
All the participants signed an informed consent at the
time of recruitment and the study protocol was approved
by the ethics committee of Tehran University of Medical
Sciences, and the board of research at Dr. Sahriati
hospoital.
Diabetes mellitus was defined as patients with fasting
blood sugar (FBS) ≥ 126 mg/dL, or 2-h postprandial
glucose ≥200 mg/dL or those who were using insulin or
oral hypoglycemic agents. Hypertensive patients were
those with systolic blood pressure of ≥than 140 or dia-
stolic blood pressure of ≥90 mmHg or were using anti-
hypertensive drugs.
Venous blood samples were drawn from the anticubi-
tal vein in the morning after 12 h fasting. The blood
samples were centrifuged, and then serum was collected
for measuring the biochemical parameters.
In all the participants, FBS and 2-h postprandial
glucose levels were measured. Plasma levels of glucose, tri-
glyceride (TG), total cholesterol, high density lipoproteincholesterol (HDL-C), low density lipoprotein cholesterol
(LDL-C), creatinine, and blood urea nitrogen (BUN) were
measured by a colorimetric method using Pars Azmoon®
kit with an autoanalyzer (Hitachi 902, Boehringer
Mannheim Germany). HbA1C was detected by High-
performance liquid chromatography (HPLC) (Knauer,
Germany), coupled with fluorescence detector. The method
was validated over a linearity range of 1–100 μmol/L of the
plasma. The intra- and interassay coefficients of variation
(CVs) for all of the measurements were <4%, which was
less than allowed CVs.
Evaluation of HRV was performed in a quiet and
temperature-controlled room according to the guidelines
of the Task Force for Pacing and Electrophysiology [5].
Participants were advised to abstain from caffeinated
food and beverages on the day of assessment. Repeat
assessments were performed at precisely the same time
of day after 48 hours. After 15 minutes of supine rest
with a regular and calm breathing pattern, a continuous
10-minute ECG recording was collected using an applana-
tion tonometer interface with HRV software (SphygmoCor,
AtCor Medical Pty, Sydney, Australia). The high-frequency
(HF band: 0.15–0.45 Hz), low-frequency (LF band: 0.04–
0.15 Hz), and very-low-frequency (VLF band: 0.01–
0.04 Hz) components of HRV (measured in absolute units;
i.e., ms2) were obtained. Total power (TP) of HRV was
also calculated to be used in regression analysis as a global
marker of cardiac autonomic function.
Normalized HF and LF powers were determined by
dividing their absolute powers by the total power minus
the VLF component and multiplied by 100 [5,12].
From the electrocardiographic recording, the following
statistical and geometric time domain indices were cal-
culated from RR intervals: standard deviation of the NN
intervals (SDNN), and the square root of the mean
squared difference of successive NNs (RMSSD). Fre-
quency domain variables including total, HF, and LF
powers and LF:HF ratio were derived from spectral
analysis of successive R-R intervals [5].
HRV measurement was performed after Valsalva and
standing maneuvers in addition to supine state, using
SphygmoCor software (SphygmoCor, AtCor Medical Pty,
Sydney, Australia). For Valsalva maneuver, the partici-
pant was requested to blow into the mouthpiece of the
device manometer to a pressure of 40 mmHg for 15
seconds. Then the Valsalva ratio was calculated as the
relationship between the longest and shortest R-R
intervals after strain. For the standing maneuver, the
participant was requested to breathe at a normal pace
for 5 minutes in the supine state. Then, the partici-
pant was asked to change position from supine to a
full upright and remain erected until the end of the
test. The standing ratio was calculated as longest R-R
interval around the 30th beat after standing up to the
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standing.
PWV was measured using the SphygmoCor System
(AtCor Medical Pty Ltd Head Office, West Ryde,
Australia), with the individual in the supine position.
The pulse waves of the carotid and femoral arteries were
analyzed, estimating the delay according to the ECG
wave and calculating PWV. PWV was calculated as the
ratio of the distance travelled (calculated as distance in
mm of distal minus proximal, where measurements are
performed from the supra-sternal notch to the sampling
site) and the foot-to-foot time delay between the pulse
waves and expressed in meters per second (m/sec).
Statistical analysis
Continuous data are presented as mean ± SD. For
comparing data with normal distribution, unpaired t-test
was used. Correlation of variables was demonstrated
using Pearson’s and Spearman’s correlation coefficients
in normal distributed parametric and nonparametric
variables, respectively. For assessment of the association
of variables, linear regression and logistic regression
were used for parametric and binary variables, respect-
ively. P-values were always 2-sided, and P < 0.05 was
considered significant. The SPSS statistical software pack-
age (version 18.0 for Windows; SPSS Inc. Chicago, IL) was
used for data analysis.Table 1 General characteristics of the study population
Characteristics Normal (N=57)
Age (years) 48.74 ± 6.18
Sex (male) % 25 (43.9)
BMI (kg/m2) 29.12 ± 5.06
Hypertension 4 (7.0)
Dyslipidemia 9 (15.8)
Smoking, n (%) 1 (1.8)
Statin use 2 (3.5)
FBS (mg/dl) 93.84 ± 13.22
Hb A1c (%) 5.31 ± 0.68
Cholesterol (mg) (mg/dl) 201.80 ± 31.04
Triglyceride (mg/dl) (mg/dl) 173.52 ± 99.17
HDL-C (mg/dl) 46.25 ± 10.74
LDL-C (mg/dl) 114.52 ± 22.43
Creatinine (mg/dl) 0.95 ± 0.13
BUN 12.88 ± 3.19
Hemoglobulin 14.87 ± 4.37
SBP (mmHg) 123.46 ± 14.09
DBP (mmHg) 77.47 ± 10.11
BMI: Body mass index; BUN: Blood urea nitrogen; DBP: Diastolic blood pressure; FBS
C-reactive protein; IFG: Impaired Fasting Glucose; LDL: Low density lipoprotein; SBPResults
A total of 64 diabetic patients (age= 52.08±8.50 years;
males=33 [51.6%]) were compared with 57 controls
(age= 48.74±6.18 years; males=25 [43.9%]) in this study.
Table 1 depicts the general characteristics and clinical
parameters of both groups. Rate of hypertension, dyslip-
idemia, and thereby systolic blood pressure and statin
use were significantly higher in the diabetic group, while
the serum levels of cholesterol, HDL-C and LDL-C were
significantly higher in the control group.
Table 2 compares the PWV and HRV indices between
the study groups. Pulse wave velocity was significantly
increased in the diabetic patients (p<0.001). RMSSD and
HRV index were significantly lower in diabetics than in
controls (p=0.02 and p<0.001, respectively). Significant
reduction of total power was also observed in the
diabetic patients relative to controls.
After adjustment for the confounding variables, inclu-
ding age, BMI, hypertension, dyslipidemia, smoking,
statin use, FBS, total cholesterol and systolic blood pres-
sure, PWV and HRV remained significantly different
between the groups (p=0.01 and p=0.004, respectively).
As HF power was highly correlated with the total
power and their observed associations were similar, we
performed our analyses using total power. Unadjusted
correlations between total power and cardiovascular pa-
rameters showed that the PWV was positively correlatedDiabetic (N=64) P-value
52.08 ± 8.50 0.15
33 (51.6) 0.39





162.60 ± 56.32 <0.001
7.95 ± 1.70 <0.001
174.12 ± 38.50 <0.001
194.08 ± 120.45 0.42
40.34 ± 8.23 0.001
95.12 ± 23.13 <0.001
0.94 ± 0.15 0.62
12.36 ± 4.15 0.45
14.30 ± 1.44 0.34
131.00 ± 17.33 0.01
76.03 ± 8.73 0.4
: Fasting blood sugar; HDL: High density lipoprotein; hs-CRP: High sensitive
: Systolic blood pressure.
Table 2 Comparing pulse wave velocity and heart rate
variability indices between the study groups
Variables Normal (N=57) Diabetic (N=64) P-value
Pulse wave velocity (m/s) 8.00 ± 1.61 10.11 ± 2.45 <0.001
RMSSD (ms) 31.78 ± 21.27 20.13 ± 19.51 0.02
HRV index 7.78 ± 2.94 5.57 ± 2.22 <0.001
Heart rate(bpm) 68.95 ± 9.44 73.64 ± 8.41 0.005
PNN 50 9.58 ± 14.56 3.01 ± 7.10 0.002
LF norm (ms2) 55.98 ± 18.79 61.65 ± 20.99 0.12
HF norm (ms2) 44.02 ± 18.78 38.34 ± 20.99 0.12
LF:HF ratio 1.83 ± 1.70 2.72 ± 2.73 0.03
Total power (ms2) 1133.17 ± 1266.26 703.73 ± 1279.76 0.06
Valsalva ratio 1.58 ± 0.28 1.44 ± 0.31 0.01
Standing ratio 1.27 ± 0.13 1.23 ± 0.20 0.29
HF: High frequency; HRV: Heart rate variability; LF: low frequency; RMSSD: the
square root of the mean squared difference.
Table 3 Partial and total correlations of the total power






Age (years) −0.42 † −0.16 −0.14
Sex (male) % 0.17 0.06 −0.07
BMI (kg/m2) 0.07 −0.23 −0.06
Hypertension 0.2 0.28 * 0.15
Dyslipidemia 0.14 0.19 0.2 *
Current smoker (%) 0.02 −0.17 −0.17
Statin use −0.11 −0.14 −0.12
FBS (mg/dl) −0.23 −0.003 −0.02
Hb A1c (%) 0.004 −0.09 0.09
Cholesterol (mg) (mg/dl) −0.04 0.04 −0.03
Triglyceride (mg/dl) (mg/dl) −0.02 0.25 * −0.08
HDL-C (mg/dl) −0.13 −0.02 −0.10
LDL-C (mg/dl) −0.04 −0.10 −0.001
Creatinine (mg/dl) −0.10 0.18 0.06
BUN −0.06 −0.05 −0.12
Hemoglobulin −0.20 0.21 0.02
SBP (mmHg) −0.10 −0.31 * −0.12
DBP (mmHg) −0.35 † −0.36 † −0.32 †
Pulse wave velocity (m/s) −0.28 * 0.37 † −0.19 *
* p<0.05.
† p<0.01.
BMI: Body mass index; BUN: Blood urea nitrogen; DBP: Diastolic blood
pressure; FBS: Fasting blood sugar; HDL: High density lipoprotein; hs-CRP: High
sensitive C-reactive protein; IFG: Impaired Fasting Glucose; LDL: Low density
lipoprotein; SBP: Systolic blood pressure.
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correlation was reverse in non-diabetic controls and
total population. Also, hypertension and triglyceride
levels were positively correlated with the total power in
the diabetic patients (Table 3).
Multiple logistic regression showed that pulse wave
velocity was independently associated with HRV index
both in diabetics and controls (Table 4). This relation-
ship showed a dose–response pattern throughout the
distribution of HRV. On the other hand, this relation
lost its significance after adjustment for diabetes and
particularly in the multiple regression model, including
age, hypertension, dyslipidemia, smoking, BMI, and
systolic blood pressure.Discussion
In this study, we observed that considerable cardiac
autonomic dysfunction exists in the uncomplicated dia-
betic patients in comparison with the normal controls,
as well as an increase in the arterial stiffness, measured
by pulse wave velocity.
Current evidence confirms that HRV is a good
measure of cardiac autonomic neuropathy in diabetic
patients and its decrease is accompanied by increased
mortality and morbidity [13]. In our study, increased
resting heart rate and decreased Valsalva ratio and
standing ratio in the diabetic patients illustrate the
parasympathetic involvement of the autonomous sys-
tem as compared with the normal controls. This has
also been shown previously both in type 1 and type 2
diabetes patients [14,15].
Decreased HRV in the uncomplicated diabetes patients
of our study and previous studies highlights the obscure
process of autonomic neuropathy in diabetic patientsthat begins even before clinical atherosclerotic cardio-
vascular disease becomes apparent [16].
It has also been shown that surrogate atherosclerosis
markers were associated with lower HRV, and increased
carotid intima media thickness (CIMT) in T2DM partic-
ipants was significantly associated with decreased HRV,
independent from conventional cardiovascular risk fac-
tors [16]. Therefore, the presence of cardiac autonomic
neuropathy should be considered much earlier in the
course of diabetes, rather than after the development of
clinical cardiovascular disease.
PWV is known as a potentially applicable atheroscler-
otic risk marker irrespective of classical cardiovascular
risk factors and ethnicity [17]. In previous studies,
arterial stiffness assessed by pulse wave analysis had a
prognostic value for cardiovascular morbidity and mor-
tality, mostly in hypertensive patients [18-20]. One study
demonstrated that increased aortic pulse wave velocity
was associated with the presence of angiographic coron-
ary artery disease in overweight and obese patients,
although the arterial stiffness indices were not consistently
Table 4 Association between pulse wave velocity and quartiles of HRV index in multivariate logistic regression model
Unadjusted OR (CI) Diabetes adjusted OR (CI) Full adjusted OR (CI)
Fist quartile of HRV index†
Second quartile of total power 0.73 (0.57, 0.92) 0.81 (0.63, 1.04) 0.93 (0.81, 1.06)
Third quartile of total power 0.51 (0.38, 0.71) 0.57 (0.41, 0.80) 0.55 (0.37, 0.84)
Fourth quartile of total power 0.55 (0.40, 0.74) 0.64 (0.47, 0.89) 0.91 (0.61, 1.37)
P trends <0.001 0.001 0.01
† First quartile of the HRV was considered as the reference.
CI: confidence interval; HRV: Heart rate variability; OR: Odd’s ratio; PWV: Pulse wave velocity.
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that cardiac parasympathetic function is a strong predictor
of large arterial stiffness, in young type 1 diabetes patients
without macrovascular and renal complications [22]. In
the Pittsburgh Epidemiology of Diabetes Complica-
tions study, cardiac autonomic neuropathy was associated
with increased arterial stiffness indices, in patients with
childhood-diagnosed type 1 diabetes [23]. Moreover, a
novel relationship between arterial stiffness, hyperinsuli-
naemia and autonomic neuropathy in a Type 2 diabetic
population has been shown in a study which signifies their
pathogenic roles in the development of cardiovascular
disease in diabetic patients [13].
Based on our findings and previous works, one could
suggest that atherosclerosis, both as a result of diabetes
and increased age is influenced by the cardiac autonomic
neuropathy, which in turn results in increased risk of
cardiovascular diseases and related mortality in the type
2 diabetes patients.
Study limitations
Among limitation to the study, we can mention that our
measurements were cross-sectional and we could not
assess how the changes in both HRV and PWV through
time, as well as the fluctuations in the serum glucose
levels and glycosated hemoglobin, affect each other. We
also did not perform glucose tolerance test in the normal
controls, so there is a probability that those with glucose
intolerance may have some degrees of disturbed HRV
and PWV. Also the effects of the type of diabetes
treatment and other prescribed medications on HRV
and PWV need to be investigated in future studies.
Conclusion
In this study, we observed increased arterial stiffness and
decreased heart rate variability in the uncomplicated
type 2 diabetes patients as compared with normal
controls. The relationship between heart rate variability
indices and pulse wave velocity was significant after
adjustment for diabetes; however, this effect was lost
after adjustment for confounders. Based on the findings
of this study, it seems that there exists a relationshipbetween heart rate variability and arterial stiffness as a
measure for atherosclerosis in diabetic patients, although
the role of the confounding factors should be taken into
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